×
About 1,010 results

ALLMedicine™ Cardioembolic Stroke Center

Research & Reviews  363 results

Hemorrhagic Transformation Following Childhood Cardioembolic Stroke Is Not Increased in...
https://doi.org/10.1177/08830738211025866
Journal of Child Neurology; Ko PY, Khalatbari H et. al.

Jan 14th, 2022 - To characterize the risk of hemorrhagic transformation following cardioembolic stroke in childhood, and whether anticoagulation impacts that risk. Ninety-five children (1 month-18 years) with cardioembolic arterial ischemic stroke between January ...

Association Between Oral Anticoagulants and Stroke Severity at Onset in Elderly Patient...
https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106264
Journal of Stroke and Cerebrovascular Diseases : the Offi... Deguchi I, Osada T et. al.

Dec 29th, 2021 - This study aimed to determine whether oral anticoagulant therapy affects the severity of cerebral infarction at onset in elderly patients with non-valvular atrial fibrillation. This retrospective study included 330 elderly patients (aged ≥75 years...

Prevalence of left atrial appendage thrombus in patients with acute ischaemic stroke an...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685935
BMJ Open; Nguyen HT, Nguyen HVB et. al.

Dec 19th, 2021 - Thrombi originating in the left atrial appendage (LAA) mainly form because of atrial fibrillation (AF) and are a known cause of cardioembolic stroke. We aimed to investigate the prevalence of LAA thrombus in patients with acute ischaemic stroke (A...

Cardiac Risk Factors for Stroke: A Comprehensive Mendelian Randomization Study.
https://doi.org/10.1161/STROKEAHA.121.036306
Stroke Frerich S, Malik R et. al.

Dec 17th, 2021 - Observational studies suggest an association of stroke with cardiac traits beyond atrial fibrillation, the leading source of cardioembolism. However, controversy remains regarding a causal role of these traits in stroke pathogenesis. Here, we leve...

Atrial fibrillation and stroke: A review and new insights.
https://doi.org/10.1016/j.tcm.2021.12.001
Trends in Cardiovascular Medicine; Escudero-Martínez I, Morales-Caba L et. al.

Dec 11th, 2021 - The link between heart and brain continues to be a matter of great interest for the scientific community. One of the most established associations between the two is that the heart is a significant source of emboli and is responsible for 20-25% of...

see more →

Clinicaltrials.gov  7 results

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
https://clinicaltrials.gov/ct2/show/NCT04695106

Nov 4th, 2021 - Health problem More than 25% of patients referred for diagnostic coronary angiography and percutaneous coronary intervention (PCI) due to acute coronary syndrome (ACS) suffer from non-valvular atrial fibrillation (AF). In this particular setting, ...

Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy
https://clinicaltrials.gov/ct2/show/NCT04676880

Sep 21st, 2021 - Stroke risk for non-valvular AF is estimated with the CHA2DS2-VASc score. When patients have no risk factors, no anticoagulation is recommended with a Class III, loe B. With 1 risk factor in men and 2 in women, anticoagulation should be considered...

Comparison of Amplatzer Amulet and Watchman Device in Patients Undergoing Left Atrial Appendage Closure. (SWISS-APERO)
https://clinicaltrials.gov/ct2/show/NCT03399851

May 24th, 2021 - Non-valvular Atrial fibrillation (NVAF) is the most common cardiac arrhythmia and a major cause of morbidity and mortality because of cardioembolic stroke. Oral anticoagulation (OAC) with vitamin K antagonists (VKA) or Non-vitamin K antagonist ant...

Canadian Pradaxa Acute Stroke Safety Study
https://clinicaltrials.gov/ct2/show/NCT02415855

Jun 19th, 2020 - Study Aim and Design: The primary aim of the CPASS registry is to demonstrate the safety of early anticoagulation with dabigatran following cardioembolic stroke. CPASS is a prospective open label single arm observational study. Safety will be esta...

An Evaluation of Clinical Pharmacist-led Intervention on Clinical Outcomes in Patients With Ischemic Stroke
https://clinicaltrials.gov/ct2/show/NCT01876667

Dec 6th, 2018 - Aim 1: Conduct a randomized, controlled, study of a clinical pharmacist-led disease management intervention for patients with a history of non-cardioembolic ischemic stroke compared to usual care. Hypothesis 1a: More patients in the clinical pharm...

see more →

News  34 results

Intracranial Atherosclerosis Finding on MRA Linked to Stroke
https://www.medscape.com/viewarticle/955993

Aug 4th, 2021 - An incidental diagnosis of intracranial atherosclerotic stenosis in stroke-free individuals should trigger a thorough assessment of vascular health, according to the authors of a study identifying risk factors and vascular event risk in asymptomat...

Small Complicated Carotid Plaques May Be Culprit in Some Strokes
https://www.medscape.com/viewarticle/940555

Nov 6th, 2020 - The presence of certain complicating features on plaques in the carotid artery are an under-recognized cause of ischemic stroke, a new study suggests. The CAPIAS (Carotid Plaque Imaging in Acute Stroke) study showed that complicated nonstenosing c...

Microbleeds Shouldn't Influence Anticoagulation After Stroke
https://www.staging.medscape.com/viewarticle/939630

Oct 22nd, 2020 - The presence of microbleeds in the brain should not affect the decision to prescribe anticoagulation to patients after an ischemic stroke, new data suggest. The new results come from a prespecified substudy of the NAVIGATE-ESUS trial, which compar...

Microbleeds Shouldn't Influence Anticoagulation After Stroke
https://www.medscape.com/viewarticle/939630

Oct 22nd, 2020 - The presence of microbleeds in the brain should not affect the decision to prescribe anticoagulation to patients after an ischemic stroke, new data suggest. The new results come from a prespecified substudy of the NAVIGATE-ESUS trial, which compar...

Atrial Fibrosis Link to ESUS Questions Stroke–AF Connection
https://www.staging.medscape.com/viewarticle/930318

May 11th, 2020 - What if atrial fibrillation (AF) turned out to be a marker of risk for cardioembolic stroke but not necessarily the direct cause of culprit thrombi? Patients with embolic stroke of undetermined source (ESUS) showed about as much atrial fibrosis on...

see more →